What is the molecular mechanism by which LRRK2-VAMP4/VAMP7 interactions regulate VGF trafficking?

OPEN

While the study demonstrates direct LRRK2-VAMP interactions and their effects on VGF transport, the specific molecular mechanisms linking these interactions to altered trafficking dynamics remain unclear. Understanding this pathway is critical for therapeutic targeting in Parkinson's disease. Gap type: unexplained_observation Source paper: Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREs. (None, None, PMID:36905628)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What is the molecular mechanism by which LRRK2-VAMP4/VAMP7 interactions regulate VGF trafficking? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What is the molecular mechanism by which LRRK2-VAMP4/VAMP7 interactions regulate VGF trafficking? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (4)

VGFTumorVGFGlioblastomaVGFAlsVGFHDAC1

associated with (28)

VGFAlzheimer'S DiseaseVGFALZHEIMER'S DISEASEVAMP7ALSVGFAlzheimerVAMP7Ms
▸ Show 23 more

biomarker for (2)

VGFAlzheimerVGFMs

expressed in (5)

VGFTumorVGFMsVGFSchizophreniaVGFCancerPI3KVGF

inhibits (1)

VGFDepression

involved in (1)

VAMP7Autophagosome-Lysosome Fusion

mediates (1)

VAMP7Autophagosome-Lysosome Fusion

regulates (8)

NPAS3VGFVGFAlzheimerVAMP7Amyotrophic Lateral SclerosisVGFMsVAMP7Als
▸ Show 3 more
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps